DNMT1 and laryngeal carcinoma: Wang et al. showed that the tobacco component nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced the expression of DNMT1 protein and its stabilization in laryngeal cancer tissues, suggesting its role in the malignant progression of the larynx [23].